Asia Pacific Transplantation Market Size & Outlook

The transplantation market in Asia Pacific is expected to reach a projected revenue of US$ 6,930.6 million by 2030. A compound annual growth rate of 11% is expected of Asia Pacific transplantation market from 2024 to 2030.
Revenue, 2023 (US$M)
$3,341.2
Forecast, 2030 (US$M)
$6,930.6
CAGR, 2024 - 2030
11%
Report Coverage
Asia Pacific

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific transplantation market, 2018-2030 (US$M)

Asia Pacific transplantation market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Asia Pacific transplantation market highlights

  • The Asia Pacific transplantation market generated a revenue of USD 3,341.2 million in 2023.
  • The market is expected to grow at a CAGR of 11% from 2024 to 2030.
  • In terms of segment, tissue products was the largest revenue generating product in 2023.
  • Immunosuppressive Drugs is the most lucrative product segment registering the fastest growth during the forecast period.
  • Country-wise, India is expected to register the highest CAGR from 2024 to 2030.


Asia Pacific data book summary

Market revenue in 2023USD 3,341.2 million
Market revenue in 2030USD 6,930.6 million
Growth rate11% (CAGR from 2023 to 2030)
Largest segmentTissue products
Fastest growing segmentImmunosuppressive Drugs
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationImmunosuppressive Drugs, Tissue Products, Preservation Solutions
Key market players worldwideAbbVie Inc, Arthrex, Zimmer Biomet Holdings Inc, Medtronic PLC, Novartis AG ADR, Stryker Corp, BioLife Solutions Inc, Teva Pharmaceutical Industries Ltd, Asahi Kasei Corp


Other key industry trends

  • In terms of revenue, Asia Pacific region accounted for 20.2% of the global transplantation market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 6,930.6 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Transplantation Market Companies

Name Profile # Employees HQ Website
Arthrex View profile 5001-10000 Naples, Florida, United States, North America https://www.arthrex.com/
BioLife Solutions Inc View profile 414 3303 Monte Villa Parkway, Suite 310, Bothell, WA, United States, 98021 https://www.biolifesolutions.com
Asahi Kasei Corp View profile 48897 1-105 Kanda Jinbocho, Chiyoda-ku, Tokyo, Japan, 101-8101 http://www.asahi-kasei.co.jp
Zimmer Biomet Holdings Inc View profile 18000 345 East Main Street, Warsaw, IN, United States, 46580 https://www.zimmerbiomet.com
Stryker Corp View profile 52000 1941 Stryker Way, Portage, MI, United States, 49002 https://www.stryker.com
AbbVie Inc View profile 50000 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 http://www.abbvieinvestor.com
Medtronic PLC View profile 95000 Lower Hatch Street, 20 On Hatch, Dublin, Ireland, 2 https://www.medtronic.com
Teva Pharmaceutical Industries Ltd View profile 37851 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 https://www.tevapharm.com
Novartis AG ADR View profile 76057 Lichtstrasse 35, Basel, Switzerland, 4056 https://www.novartis.com

Asia Pacific transplantation market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to transplantation market will help companies and investors design strategic landscapes.


Tissue products was the largest segment with a revenue share of 57.19% in 2023. Horizon Databook has segmented the Asia Pacific transplantation market based on immunosuppressive drugs, tissue products, preservation solutions covering the revenue growth of each sub-segment from 2018 to 2030.


The Asia Pacific region consists of emerging economies like Japan, China, and India. These countries have large population base with high incidence of chronic diseases. Increase in the number of chronic diseases that lead to organ failure is expected to boost transplant market growth.

The low cost of surgical procedures in the region allows large number of patients to visit for medical reasons. Thus, increase in the number of chronic diseases leading to organ failure and rise in medical tourism has contributed significantly to the growth of the transplantation market in the region.

Reasons to subscribe to Asia Pacific transplantation market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Asia Pacific transplantation market databook

  • Our clientele includes a mix of transplantation market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific transplantation market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific transplantation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Asia Pacific transplantation market size, by country, 2018-2030 (US$M)

Asia Pacific Transplantation Market Outlook Share, 2023 & 2030 (US$M)

Asia Pacific transplantation market size, by country, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online